Skip to content
Checked.be
Complete company report
Generated 26-07-2026
Active BE 0810.070.556Private limited company

WE-PHARMA

Rue Sous-le-Château 51 ·4500 Huy, Belgium· 17 yrs active
Sector: NACE 82920 (82920)
Conclusion Checked

The computed 12-month bankruptcy probability of WE-PHARMA is 0.3% (very low). The company has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 17 yrs
Board 6
Locations 1
Publications 9
Bankruptcy probability (12 mo) Checked model v1 · free
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Long track record −Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 3 signals
Established
Founded in 2009, 17 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags 0 events
No administrative flags
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 07-07-2025 2025-00244602
31-12-2023 volledig 30-08-2024 2024-00430148
31-12-2022 micro 31-07-2023 2023-00308754
31-12-2021 micro 20-09-2022 2022-20435710
31-12-2020 volledig 23-11-2021 2021-78100209
31-12-2019 volledig 14-10-2020 2020-61800246
31-12-2018 volledig 18-07-2019 2019-35300100
31-12-2017 volledig 08-10-2018 2018-69200061
31-12-2016 volledig 31-08-2017 2017-59900182
31-12-2015 volledig 14-12-2016 2016-70000378
Directors & mandates 9 directors
Current directors & mandates
  • ASSURANCES DES COLLINESLegal entity
    Director· perm. rep.: Sandrine LUCAS
    State Gazette act 25368432 (07-11-2025)
    Current
    07-11-2025 → present
  • BRUSSELAERS Nathalie
    Director
    State Gazette act 25368432 (07-11-2025)
    Current
    07-11-2025 → present
  • JOURET SANDRINELegal entity
    Director· perm. rep.: Hafida AFKIR
    State Gazette act 25368432 (07-11-2025)
    Current
    07-11-2025 → present
  • SRL ISLALegal entity
    Director· perm. rep.: Stefan OTTE
    State Gazette act 25368432 (07-11-2025)
    Current
    07-11-2025 → present
  • SRL TORALIUSLegal entity
    Director· perm. rep.: Jean-Marc DUPAS
    State Gazette act 25368432 (07-11-2025)
    Current
    07-11-2025 → present
  • SAGAFILLegal entity
    Director· perm. rep.: LUCAS Sandrine
    State Gazette act 24325500 (15-01-2024)
    Current
    15-01-2024 → present
Historic, not recently confirmed (1)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • Sagafil SNCLegal entity
    Managing director· perm. rep.: Lucas Sandrine
    State Gazette act 15120268 (20-08-2015)
    Not recently confirmed
    last confirmed in an act from 2015
Former directors (2)
  • Comté
    Managing director
    State Gazette act 15120268 (20-08-2015)
    Former
    - → 20-07-2015
  • Gérard
    Managing director
    State Gazette act 15120268 (20-08-2015)
    Former
    - → 20-07-2015
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor 1 auditor
Statutory auditor IRE/IBR number Tenure
REMON & CO, Réviseurs d’EntreprisesCurrent
Company auditor · represented by REMON Christophe
 - 23-12-2025 → present
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary 82920
Legal form Private limited company(610)
Incorporation26-02-2009
StatusActive
Postal code4500
Connections & network 2 connected companies
Group structure
ASSURANCES DES COLLINES
Parent · 1 subsidiary · 1 location
Control→
JOURET SANDRINE
Parent · 1 subsidiary
Control→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Establishment units 1 location
WE-PHARMA
Rue Sous-le-Château 51, 4500 HuyOverige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.
since 20092.177.084.430
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Updates 19 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
15-04-2026
State Gazette act Capital & shares
Didier NELLESSEN
2025
30-12-2025
State Gazette act Statutes amendment
v3.2
07-11-2025
State Gazette act Capital & shares
v3.2
07-07-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
12-03-2025
State Gazette act Statutes amendment
v3.2
2024
06-11-2024
State Gazette act Capital & shares
v3.2
30-08-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
04-06-2024
State Gazette act Statutes amendment
v3.2
09-02-2024
State Gazette act Statutes amendment
v3.2
15-01-2024
State Gazette act Statutes amendment
v3.2
2023
31-07-2023
NBB filing Annual accounts filed
fiscal year 2022 · micro
2022
20-09-2022
NBB filing Annual accounts filed
fiscal year 2021 · micro
2021
23-11-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
2020
14-10-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
2019
18-07-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
2018
08-10-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
2017
31-08-2017
NBB filing Annual accounts filed
fiscal year 2016 · volledig
2016
14-12-2016
NBB filing Annual accounts filed
fiscal year 2015 · volledig
2015
20-08-2015
State Gazette act Director changes
v3.2
Belgisch Staatsblad, acts 9 acts
Capital history · 3
15-04-2026
Capital change
07-11-2025
v3.2
06-11-2024
v3.2
All acts · 9 updated 3 months ago
2026
15-04-2026 Capital increase of €288,288.87 to €288,288.87 Capital & shares·Didier NELLESSEN
  • €0 → €288.288,87
Notary: Didier NELLESSEN · Huy
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 288288.87,
      "delta_eur": 288288.87,
      "before_eur": 0.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "BRUSSELAERS Vincent",
          "share_class": "D",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 110700,
          "contribution_amount_eur": 100000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "DRION Charles-Antoine",
          "share_class": "D",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 110700,
          "contribution_amount_eur": 100000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "BUNKENS Geert",
          "share_class": "D",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 38577,
          "contribution_amount_eur": 34848.41
        },
        {
          "kbo": "0873.531.619",
          "rrn": null,
          "kind": "org",
          "name": "CH INVEST",
          "share_class": "D",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 59158,
          "contribution_amount_eur": 53440.46
        }
      ],
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": null,
        "share_form": "nominal",
        "share_class": "D",
        "n_new_shares": 319135,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 288288.87,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Didier NELLESSEN",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Huy",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2026-04-15",
    "filing_date": "2026-04-13",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2026-04-02",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": null,
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Christophe REMON"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Sandrine LUCAS",
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition de l\u2019acte",
    "coordination des statuts"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "BRUSSELAERS Vincent",
      "role": "aandeelhouder",
      "n_shares": 110700,
      "share_class": "D"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "DRION Charles-Antoine",
      "role": "aandeelhouder",
      "n_shares": 110700,
      "share_class": "D"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "BUNKENS Geert",
      "role": "aandeelhouder",
      "n_shares": 38577,
      "share_class": "D"
    },
    {
      "kbo": "0873.531.619",
      "pct": null,
      "kind": "org",
      "name": "CH INVEST",
      "role": "aandeelhouder",
      "n_shares": 59158,
      "share_class": "D"
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 69839,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 575687,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 193746,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 1919897,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.03
    },
    {
      "n_shares": 586168,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.02
    },
    {
      "n_shares": 1557989,
      "class_name": "F",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.01
    }
  ]
}
2025
30-12-2025 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-12-23",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "l\u2019autre justificatif de l\u2019int\u00E9r\u00EAt des apports pour la soci\u00E9t\u00E9, \u00E9tablis conform\u00E9ment aux articles 5 :121 \u00A71er et 5 :133 du Code des Soci\u00E9t\u00E9s et des Associations. ... Le rapport de Monsieur REMON, conclut dans les termes suivants : ... pour laquelle j\u2019ai \u00E9t\u00E9 d\u00E9sign\u00E9s par lettre de mission du 17 novembre 2025.",
    "firm_kbo": null,
    "firm_name": "REMON \u0026 CO, R\u00E9viseurs d\u2019Entreprises",
    "ibr_number": null,
    "individual_name": "REMON Christophe"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale extraordinaire d\u00E9cide \u00E9galement de charger le Notaire instrumentant de la coordination des statuts.",
      "holder_kbo": null,
      "holder_name": "Notaire instrumentant",
      "scope_categories": [
        "coordination des statuts"
      ],
      "with_substitution": false
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}
07-11-2025 Capital increase of €695,064 Capital & shares
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 695064,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 695064,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-10-30",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u2019augmenter les apports disponibles en soci\u00E9t\u00E9, \u00E0 concurrence de six cent nonante-cinq mille soixante-quatre euros (695.064 EUR)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  }
}
12-03-2025 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-03-10",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}
2024
06-11-2024 Capital increase of €575,000 Capital & shares
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 575000,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 575000,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-11-04",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u2019augmenter les apports disponibles en soci\u00E9t\u00E9, \u00E0 concurrence de CINQ CENT SEPTANTE-CINQ MILLE euros (575.000 EUR), par la cr\u00E9ation de onze mille huit cent soixante-quatre (11.864) nouvelles actions... L\u2019assembl\u00E9e g\u00E9n\u00E9rale pr\u00E9cise que la totalit\u00E9 de l\u2019apport suppl\u00E9mentaire en num\u00E9raire est affect\u00E9 au compte \u00AB capitaux propres \u00BB disponible.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  }
}
04-06-2024 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-05-31",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}
09-02-2024 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-02-02",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}
15-01-2024 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-12-27",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SPRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}
2015
20-08-2015 1 director appointed, 2 resigning Director changes
  • Lucas Sandrine, Gedelegeerd bestuurder
  • Comté, Gedelegeerd bestuurder
  • Gérard, Gedelegeerd bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Comt\u00E9",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-07-20",
      "evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e accepte la d\u00E9mission de Mesdames Comt\u00E9 et G\u00E9rard de leur poste de g\u00E9rante avec effet au 20 juillet prochain.",
      "discharge_granted": true
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "G\u00E9rard",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-07-20",
      "evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e accepte la d\u00E9mission de Mesdames Comt\u00E9 et G\u00E9rard de leur poste de g\u00E9rante avec effet au 20 juillet prochain.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Lucas Sandrine",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Sagafil SNC",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2015-07-20",
      "evidence_quote": "L\u0027assembl\u00E9e nomme au poste de g\u00E9rante la soci\u00E9t\u00E9 Sagafil SNC, repr\u00E9sent\u00E9e par sa g\u00E9rante, Madame Sandrine Lucas, cette nomination prendra \u00E9galement effet au 20 juillet prochain."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0810.070.556",
    "name_full": "WE-PHARMA",
    "legal_form": "SPRL"
  }
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE) Crossroads Bank
Activities
Apotheken47730Detailhandel in farmaceutische producten47730Activiteiten van verpakkingsbedrijven82920Detailhandel in farmaceutische producten47730
Primary activity highlighted.
Names & trade names
Legal nameFR WE-PHARMA
Registered office
Rue Sous-le-Château 51
4500 Huy, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
"SEPARATION" AG BE 0699.788.385 · Raeren
CANDY PACK BELGIUM BE 0809.543.588 · Verviers
HiFoodTec BE 0684.507.026 · Herve
IN'TOLERANCE BE 1013.531.026 · Verviers
INFOLOGIC BE 0837.103.070 · Beyne-Heusay
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative